The REgistry Study on Multimodality trEAtment foR Cerebral Hemorrhage

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorTao Liu

About this trial

The REgistry Study on multimodality trEAtment foR Cerebral Hemorrhage (RESEARCH) aims to address these challenges by establishing a comprehensive national registry. This initiative will collect detailed, longitudinal data on the clinical characteristics, treatment modalities, and outcomes of patients with ICH across various regions. By leveraging a wide array of treatment data - including medical management, surgical interventions, and rehabilitative strategies - the RESEARCH registry intends to provide a granular view of current treatment landscapes and their direct impact on patient recovery and quality of life.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Cerebral hemorrhage

Disqualifiers

None

Trial population

Cerebral hemorrhage from various causes

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • medical management, surgical interventions, and rehabilitative strategies

    Other intervention

    By leveraging a wide array of treatment data - including medical management, surgical interventions, and rehabilitative strategies - the RESEARCH registry intends to provide a granular view of current treatment landscapes and their direct impact on patient recovery and quality of life.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

modified Rankin Score (mRS)

0=no symptoms, 1=no significant disability, 2=slight disability, 3= moderate disability, 4=moderate severe disability, 5=severe disability, 6=death

Time frame
at least 6 months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tao Liu

Lead sponsor

The George Institute

Sponsor institution

Tianjin Medical University General Hospital

Collaborator

Xuanwu Hospital, Beijing

Collaborator

This trial is not recruiting at the moment. You can still explore other options: